While reporting financial results for the first quarter, Boston Scientific Corp. (BSX) on Wednesday adjusted its earnings and revenue growth guidance for the full-year 2019 and also provided outlook for the second quarter below estimates.
from RTT - Earnings http://bit.ly/2IFbl7k
via IFTTT
No comments:
Post a Comment